SCHEMBL2637594

SCHEMBL2637594

O=c1[nH]n2c(=O)cc(-c3cc(Cl)cc(Cl)c3)[nH]c2c1Nc1ccccc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAT2A P31153 1/20 0.37
MAPT P10636 5/20 0.34
ALDH1A1 P00352 3/20 0.34
HPGD P15428 3/20 0.34
KDM4E B2RXH2 1/20 0.34
APAF1 O14727 1/20 0.34
THRB P10828 1/20 0.34
CDC25B P30305 1/20 0.34
CASP3 P42574 1/20 0.34
RECQL P46063 1/20 0.34
GALK1 P51570 1/20 0.34
UBE2I P63279 1/20 0.34
SMAD3 P84022 1/20 0.34
SENP8 Q96LD8 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34
SAE1 Q9UBE0 1/20 0.34
UBA2 Q9UBT2 1/20 0.34
ATG4B Q9Y4P1 1/20 0.34
MEN1 O00255 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637972 0.91 MEN1 (0.41) MAT2AMAPTALDH1A1HPGDKDM4E
SCHEMBL2637590 0.91 KDM4E (0.41) MAT2AMAPTALDH1A1HPGDKDM4E
SCHEMBL2638843 0.88 MAPT (0.35) MAPTALDH1A1HPGDKDM4EAPAF1
SCHEMBL2637584 0.86 MET (0.39) MAT2AMAPTALDH1A1HPGDKDM4E
SCHEMBL2637795 0.81 MEN1 (0.44) MAPTALDH1A1HPGDKDM4ECDC25B
SCHEMBL2637170 0.81 MAPT (0.43) MAT2AMAPTALDH1A1HPGDKDM4E
SCHEMBL2637246 0.80 MAPK10 (0.41) MAPTMEN1KMT2ARAB9ANPSR1
SCHEMBL2637722 0.79 PSD (0.39) MAPTALDH1A1HPGDKDM4EAPAF1
SCHEMBL2637716 0.77 KMT2A (0.47) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL2637406 0.76 MAPT (0.41) MAPTALDH1A1HPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed